Physician profile
Maria Gonzales
NPI 1942044326
$980.81
in general payments reported to CMS, 2019-2025
12 companies · $615 in 2025
The $615 reported for 2025 was more than what 77% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $366 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $261.25 | 2025 | |
| Urgo Medical North America, LLC | $162.98 | 2025 | Urgoclean Ag, Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Paratek Pharmaceuticals, INC. | $139.02 | 2024 | Nuzyra |
| Mimedx Group, INC. | $72.59 | 2024-2025 | |
| Hartmann USA, INC. | $68.44 | 2024-2025 | Zetuvit Plus 10x10 P10, Twopress 2, Twopress 2 Lite, 10cm |
| Abbvie INC. | $66.32 | 2024 | |
| Surgenex LLC | $61.87 | 2025 | Renograft, Ardeograft, Surgraft |
| Acera Surgical, INC. | $43.94 | 2024 | Restrata Wound Matrix |
| Solventum Corporation | $40.66 | 2024 | Activ.A.C. |
| Hydrofera LLC | $27.63 | 2025 | Hydrofera Blue |
| Integra Lifesciences Corporation | $19.06 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $17.05 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Gonzales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.